Coronavirus infections and type 2 diabetes-shared pathways with therapeutic implications
Open accessThe DOI matches its Crossref record; 130 of the 132 references it cites were found in a registry or an index.
Abstract
Individuals with diabetes are at increased risk for bacterial, mycotic, parasitic, and viral infections. The severe acute respiratory syndrome (SARS)-CoV-2 (also referred to as COVID-19) coronavirus pandemic highlights the importance of understanding shared disease pathophysiology potentially informing therapeutic choices in individuals with type 2 diabetes (T2D). Two coronavirus receptor proteins, angiotensin-converting enzyme 2 (ACE2) and dipeptidyl peptidase-4 (DPP4) are also established transducers of metabolic signals and pathways regulating inflammation, renal and cardiovascular physiology, and glucose homeostasis. Moreover, glucose-lowering agents such as the DPP4 inhibitors, widely used in subjects with T2D, are known to modify the biological activities of multiple immunomodulatory substrates. Here, we review the basic and clinical science spanning the intersections of diabetes, coronavirus infections, ACE2, and DPP4 biology, highlighting clinical relevance and evolving areas of uncertainty underlying the pathophysiology and treatment of T2D in the context of coronavirus infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“however, just like for ACE inhibitors, there is currently insufficient scientific evidence to judge whether use of DPP4 inhibitors impacts adversely on type 2 diabetes patients with COVID-19 (28).”
From ENDOCRINOLOGY IN THE TIME OF COVID-19: Management of adrenal insufficiency (2020) · cites this paper as [28]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical characteristics of coronavirus disease 2019 in China
Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246
Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286
Lu, R., Zhao, X., Li, J., Niu, P., Yang, B., Wu, H., Wang, W., Song, H., Huang, B., Zhu, N., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30251-8 · Cited by 11,907
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
Marso, S. P., Daniels, G. H., Brown-Frandsen, K., Kristensen, P., Mann, J. F. E., Nauck, M. A., Nissen, S. E., Pocock, S., Poulter, N. R., Ravn, L. S., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1603827 · Cited by 7,629 · cited 1×
“The results of several large studies examining the cardiovascular safety of GLP-1R agonists did not reveal imbalances in rates of inflammatory disorders or severe infections (113) (114) (115) (116) .”
ResultSemaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
Marso, S. P., Bain, S. C., Consoli, A., Eliaschewitz, F. G., Jódar, E., Leiter, L. A., Lingvay, I., Rosenstock, J., Seufert, J., Warren, M. L., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1607141 · Cited by 6,900 · cited 1×
“The results of several large studies examining the cardiovascular safety of GLP-1R agonists did not reveal imbalances in rates of inflammatory disorders or severe infections (113) (114) (115) (116) .”
ResultHamming, I., Timens, W., Bulthuis, M., Lely, A., Navis, G., & van Goor, H. (2004) · The Journal of Pathology · doi:10.1002/path.1570 · Cited by 5,676 · cited 9×
“1), and generates vasodilatory Ang (1-7), collectively modulating often opposing actions of Ang II and ACE through Ang and angiotensin (1-7) receptors.”
BackgroundInfluentialGrasselli, G., Zangrillo, A., Zanella, A., Antonelli, M., Cabrini, L., Castelli, A., Cereda, D., Coluccello, A., Foti, G., Fumagalli, R., et al. (2020) · JAMA · doi:10.1001/jama.2020.5394 · Cited by 5,469 · cited 2×
“form ACE2(1-740), however the biological importance of sACE2 remains uncertain.”
BackgroundCase-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy
Onder, G., Rezza, G., & Brusaferro, S. (2020) · JAMA · doi:10.1001/jama.2020.4683 · Cited by 4,171
Comorbidity and its impact on 1590 patients with covid-19 in China: a nationwide analysis
Guan, W.-J., Liang, W.-H., Zhao, Y., Liang, H.-R., Chen, Z.-S., Li, Y.-M., Liu, X.-Q., Chen, R.-C., Tang, C.-L., Wang, T., et al. (2020) · European Respiratory Journal · doi:10.1183/13993003.00547-2020 · Cited by 3,680
Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus
Scirica, B. M., Bhatt, D. L., Braunwald, E., Steg, P. G., Davidson, J., Hirshberg, B., Ohman, P., Frederich, R., Wiviott, S. D., Hoffman, E. B., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1307684 · Cited by 3,470 · cited 2×
“Consistent with these findings, results of large trials examining the safety of saxagliptin, alogliptin, sitagliptin, and linagliptin in humans with T2D at risk for cardiovascular or renal disease did not reveal clinically relevant safety concerns related to infections, immune or inflammatory disorders (96-100).”
BackgroundResult
Research works printed but not linked: 1
- Audit I. ICNARC Report on COVID-19 in Critical Care. In. April 10 2020 ed: London, UK: Intensive Care National Audit & Research Centre (ICNARC); 2020. https:// www.icnarc.org/About/Latest-News/2020/04/04/ Report-On-2249-Patients-Critically-Ill-With-Covid-19
Cited by
Items 301–400 of 433
Karnaushkina, M. A., Викторовна, Т. С., Antonova, E. V., Matsyuk, N. V., Vasilyeva, I. S., Strutynskaya, A. D., & Tyurin, I. E. (2021) · Bulletin of Siberian Medicine · doi:10.20538/1682-0363-2021-1-50-58 · Cited by 2
O IMPACTO DA PANDEMIA DO CORONAVÍRUS NA SAÚDE MENTAL DOS PROFISSIONAIS DE SAÚDE
Sarmento, A. M. P., Gomes, A. C. Á., Dornelas, D. H. D. S., Teixeira, F. D. C., Oliveira, J. S. D., Canêdo, J. A., Batista, L. M., Marques, L. A. M., Pereira, R. L., SCHACHT, V., et al. (2021) · doi:10.22533/at.ed.5942102096 · Cited by 2
A clinical case of using gliclazide MR in a patient with type 2 diabetes mellitus
Кононенко, И. В., & Smirnova, O. M. (2021) · Endocrinology News Opinions Training · doi:10.33029/2304-9529-2021-10-4-79-86 · Cited by 2
Historical Epidemiology and the Single Pathogen Model of Epidemic Disease
Webb, J. L. A. (2022) · Centaurus · doi:10.1484/j.cnt.5.128364 · Cited by 2
What hematological and endocrinal indicators are important in COVID-19 infection?
Ostadrahimi, A., Sadra, V., Bahrami, A., Razaghi, Z., Najafipour, M., Tutunchi, H., & Najafipour, F. (2022) · Health Promotion Perspectives · doi:10.34172/hpp.2022.26 · Cited by 2
Sonkar, G. K., Singh, S., & Sonkar, S. K. (2022) · Journal of Diabetology · doi:10.4103/jod.jod_87_22 · Cited by 2
Inflammatory Modulation of Interleukin-17 and -23 in Long COVID Diabetic Patients
Ali, E. H. A. (2024) · Journal of Angiotherapy · doi:10.25163/angiotherapy.839583 · Cited by 2
Sauter, K. A. D., Webb, G. M., Bader, L., Kreklywich, C. N., Takahashi, D. L., Zaro, C., McGuire, C. M., Lewis, A. D., Colgin, L. M. A., Kirigiti, M. A., et al. (2025) · PLoS Pathogens · doi:10.1371/journal.ppat.1012988 · Cited by 2
Opportunities for Research for COVID-19 in the Mission of NIDDK
Cefalu, W. T., James, S. P., & Star, R. A. (2020) · Diabetes Care · doi:10.2337/dci20-0025 · Cited by 2
Luo, G., & Zhu, W. P. (2021) · World Journal of Advanced Research and Reviews · doi:10.30574/wjarr.2021.9.2.0035 · Cited by 2
Coronavirus Disease 2019: An Overview of the Complications and Management
Shao, H., Ghaly, H. S. A., & Varamini, P. (2021) · INNOSC Theranostics and Pharmacological Sciences · doi:10.36922/itps.v4i1.1037 · Cited by 2
Obravnava bolnikov s sladkorno boleznijo v času epidemije covida-19
Janić, M., Lunder, M., & Janež, A. (2021) · Slovenian Medical Journal · doi:10.6016/zdravvestn.3093 · Cited by 2
Malaria, COVID-19 and angiotensin-converting enzyme 2: what does the available population data say?
De, A., Dash, M., Tiwari, A., & Sinha, A. (2021) · Open Biology · doi:10.1098/rsob.210213 · Cited by 2
Pombo, A. F., Santamar�a-Nieto, A., Rodríguez-Carnero, G., D�az-Trastoy, O., Andújar-Plata, P., R�bade-Castedo, C., Pena-Dubra, A., & Villar-Taibo, R. (2000) · Galicia Clínica · doi:10.22546/62/2561 · Cited by 2
Second Update for Anaesthetists on Clinical Features of COVID-19 Patients and Relevant Management
Weenink, R. P., Preckel, B., Hulst, A. H., Hermanides, J., de Jong, M. D., Schlack, W. S., Stevens, M. F., Weiland, N. H. S., & Hollmann, M. W. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9082542 · Cited by 2
Current management of diabetes patients with COVID-19
Misra, A. K., Rangari, G. M., Madhavrao, C., & Sharma, S. K. (2023) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2023.2187215 · Cited by 2
Yang, Y., Zhao, L., Wang, Y., Liu, C., & Ke, T. (2023) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-023-01228-x · Cited by 2
Saravanan, P., Ganesan, R., Panneerselvam, D., Iyakannu, P., Ravindra, S., Ranganathan, V., Rajendran, K., Ellappan, D., Raman, V., Ammapalayam, P. K., et al. (2023) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-023-01247-8 · Cited by 2
The Management of Diabetes Mellitus in Patients with COVID-19
Ingle, P. V., Ling, C. X., Kamar, A. K. D. B. A., Hui, Y. L., Yean, C. Z., & Cheng, J. L. J. (2024) · The Review of Diabetic Studies · Cited by 2
Asadipooya, K. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac450 · Cited by 2
An insight to the diabetic ketoacidosis and lactic acidosis among the SARS-COV2 infected individuals
Al-Sa'idy, H. A. H., Al‐Snafi, A. E., & Alyousif, B. (2022) · Magna Scientia Advanced Biology and Pharmacy · doi:10.30574/msabp.2022.6.1.0071 · Cited by 1
Al-Samarra, E. A. A. K., & Al-Samarrai, R. R. H. (2022) · AIP conference proceedings · doi:10.1063/5.0095332 · Cited by 1
The Impact of COVID-19 (SARS-CoV-2) Virus Infection on the Endocrine System: A Review Study
Azarkish, F., Halvaei, I., Kazemi, H., Dehghani, A., Kheirandish, M., & Sohrabipour, S. (2022) · Disease and Diagnosis · doi:10.34172/ddj.2022.31 · Cited by 1
Evaluation of the antioxidant state in type 2 diabetes mellitus patients with COVID-19
Al-Samarra, E. A. A. K., & Al-Samarrai, R. R. H. (2022) · AIP conference proceedings · doi:10.1063/5.0122504 · Cited by 1
Deora, N., & Venkatraman, K. (2024) · Journal of Herbal Medicine · doi:10.1016/j.hermed.2024.100923 · Cited by 1
Chen, Q., He, H., Zhu, Y., Li, X. O., Fang, J., Li, Z., Liu, P., Zhou, L. M., Pan, Y., & Wu, G. (2025) · Molecules · doi:10.3390/molecules30051055 · Cited by 1
Raju, G. S., & Reddy, B. P. (2021) · International Journal of Advanced Research in Medicine · doi:10.22271/27069567.2021.v3.i1i.611 · Cited by 1
Patrick, M. D., Foster, A., Aneja, A., & Annamalai, R. T. (2025) · Journal of Medical Virology · doi:10.1002/jmv.70654 · Cited by 1
Rodina, L., Monescu, V., Caplan, L. G., Cocuz, M. E., & Bîrluțiu, V. (2026) · COVID · doi:10.3390/covid6020025 · Cited by 1
Zoonotic Spillover Mechanisms of Emerging Viral Pathogens at the Wildlife–Livestock Interface
Akhtar, D. N., Gajian, W., Aziz, K. J., & Usman, S. (2026) · Physical Education Health and Social Sciences · doi:10.63163/jpehss.v4i1.1107 · Cited by 1
Sosa-Caballero, A., León-Suárez, A., Segovia-Palomo, A., Márquez-Rodríguez, E., Lavalle-González, F. J., Garnica-Cuéllar, J. C., Mancillas-Adame, L. G., Arizpe, L. H., Almeda-Valdés, P., Faradji-Hazan, R. N., et al. (2020) · Revista Mexicana de Endocrinología Metabolismo y Nutrición · doi:10.24875/rme.20000044 · Cited by 1
COVID-19 i farmakološka terapija šećerne bolesti tipa 2
Bulum, T. (2020) · Hrčak Portal of scientific journals of Croatia (University Computing Centre) · Cited by 1
Diabetes mellitus in combination with COVID-19: modern views on therapy
Tsymbaliuk, V. I., Tronko, M. D., Antypkin, Y. G., Kushnirenko, S. V., & Попова, В. В. (2021) · Reproductive Endocrinology · doi:10.18370/2309-4117.2021.57.8-20 · Cited by 1
COVID-19 SALGININDA DİYABET YÖNETİMİ VE HEMŞİRENİN ROLÜ
Besen, D. B., & Dervişoğlu, M. (2021) · Gazi Sağlık Bilimleri Dergisi · doi:10.52881/gsbdergi.887427 · Cited by 1
Manejo ambulatorio del paciente con diabetes en tiempos de COVID-19
Rincón, A. R., & Builes-Montaño, C. E. (2020) · Revista Colombiana de Endocrinología Diabetes & Metabolismo · doi:10.53853/encr.7.2s.587 · Cited by 1
Veettil, M. V., Gopi, P., Anju, T. R., & Pillai, V. S. (2021) · Current Drug Targets · doi:10.2174/1389450122666210917113842 · Cited by 1
Vultur, M. A. (2021) · The Medical-Surgical Journal · doi:10.22551/msj.2021.03.08 · Cited by 1
Outpatient Management of Type 2 Diabetes Mellitus
Lee, D., & Zonszein, J. (2022) · Springer eBooks · doi:10.1007/978-3-030-84367-0_40 · Cited by 1
Correlation of Diabetes Mellitus and COVID-19: A Review
Patel, M. H., Agolli, A., Rocha, M. D. C., Nunes, L. R., Mistry, H. G., Patel, Z. H., Adhvaryu, M., Agolli, O., Vahora, I. S., Bhatt, K. P., et al. (2021) · Diabetes & its Complications · doi:10.33425/2639-9326.1087 · Cited by 1
Clinical characteristics and managing type 2 diabetes during the COVID-19
Risović, I., Djekic, D., Vuković, B., & Vlatković, V. (2022) · Clinical Diabetology · doi:10.5603/dk.a2022.0010 · Cited by 1
Alhozali, A. M., Khedher, Y. Z., Qari, R., & Nughays, R. (2022) · The Egyptian Journal of Hospital Medicine · doi:10.21608/ejhm.2022.223616 · Cited by 1
Al-Sa'idy, H. A. H., Alyousif, B., & Al‐Snafi, A. E. (2022) · GSC Biological and Pharmaceutical Sciences · doi:10.30574/gscbps.2022.19.1.0142 · Cited by 1
COMPLICACIONES DE COVID-19 ASOCIADAS A LA OBESIDAD: REVISIÓN
Suero, L. E. L., Vásquez-Guillén, M., Vásquez-Guillén, A., Contreras, M., & Carrero, Y. N. (2022) · Enfermería Investiga · doi:10.31243/ei.uta.v7i2.1619.2022 · Cited by 1
Acute Complications of Diabetes with COVID-19
Романовский, А. А., Ярошевич, Н. А., Lushchik, M. L., Радюк, Д. В., Бурко, И. И., & Данилова, Л. И. (2020) · Рецепт · doi:10.34883/pi.2020.2.2.047 · Cited by 1
Inhibitors of dipeptidyl-peptidase-4: obvious and probable (literature review)
Ortenberg, E. A., & Суплотова, Л. А. (2022) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2022-16-10-40-45 · Cited by 1
Гуревич, К. Г., Sorokina, Y. А., Ураков, А. Л., Sinyushkina, S. D., Pryazhnikova, M. I., Gorinova, A. V., Ловцова, Л. В., & Занозина, О. В. (2022) · Reviews on Clinical Pharmacology and Drug Therapy · doi:10.17816/rcf203269-279 · Cited by 1
Respiratory support for pneumonia patients in the COVID-19 pandemic
Mirsaliyev, M., Исраилова, В. К., Kashikova, K., Ismailov, Z., & Kozhamberdiyeva, D. (2022) · Journal of Pharmaceutical Negative Results · doi:10.47750/pnr.2022.13.03.098 · Cited by 1
Sickeningly Sweet: Infectious Complications of Diabetes
Zhang, R. M., McKee, A. M., & Anderson, N. W. (2023) · Clinical Microbiology Newsletter · doi:10.1016/j.clinmicnews.2023.01.001 · Cited by 1
Bacterial degradation of emerging pollutants from paper industry wastewater
Kumar, R., & Raj, A. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-91902-9.00012-2 · Cited by 1
ASSOCIATION BETWEEN TYPE 2 DIABETES MELLITUS AND COVID-19 SEVERITY: A LITERATURE REVIEW
Gowthavaram, C. A. (2023) · Asian Journal of Pharmaceutical and Clinical Research · doi:10.22159/ajpcr.2023.v16i5.47961 · Cited by 1
Colón-Arias, F., Sebelén, E. B., García, N., Ramírez, L., Pereyra-Bencosme, K., Vargas, C., Tejada-Toribio, F., Soriano, G. A. T., & Gutiérrez-Martínez, A. (2023) · Ciencia y Salud · doi:10.22206/cysa.2023.v7i2.pp17-30 · Cited by 1
The Association Between Some Endocrine Conditions and COVID-19: A Review
Smail, H. O. (2022) · Biology Medicine & Natural Product Chemistry · doi:10.14421/biomedich.2023.121.45-53 · Cited by 1
Abo-Elfadl, H. I., & Morsy, G. M. (2023) · Egyptian Academic Journal of Biological Sciences. C, Physiology and Molecular Biology/Egyptian Academic Journal of Biological Sciences. C, Physiology and Molecular Biology · doi:10.21608/eajbsc.2023.321787 · Cited by 1
COVID-19 and type 1 and 2 diabetes: An overview
Askari, V. R., & Rahimi, V. B. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95646-8.00041-x · Cited by 1
Development of hypoglycemia in patients with COVID-19: coincidence or the result of treatment?
Halushko, O. A., Saienko, Y. A., & Mankovsky, B. (2024) · Ageing & Longevity · doi:10.47855/jal-2024-5-4 · Cited by 1
Riscos de infecção por SARS-CoV-2 e COVID-19 em mulheres com síndrome dos ovários policísticos
de Medeiros, S. F., de Medeiros, M. A. S., Carvalho, A. B. D. S., Yamamoto, A. K. L. W., & Yamamoto, M. M. W. (2022) · Femina · doi:10.61622/0100-72545010202208 · Cited by 1
COVID-19 Comorbidity and Metabolic Syndrome: Is There a Molecular Basis?Preprint
Basu, M., Saha, C., Choudhury, K. R., Dutta, S., Ghosh, S. K., Chowdhury, S., Mukhopadhyay, S., & Bhattacharyya, N. P. (2020) · Preprints.org · doi:10.20944/preprints202006.0245.v1 · Cited by 1
Diabetes Care During the COVID-19 Pandemic
Zelada, H., Babcock, H. M., & Carmichael, K. A. (2020) · Consultant · doi:10.25270/con.2020.05.00017
Review of the SARS-CoV-2 in Wuhan and Analysis as Well as Prediction of Therapeutic Drugs
Zhang, R., & Tang, Y. (2020) · Viral Immunology · doi:10.1089/vim.2020.0027
In-patient Care for People with COVID-19 and Diabetes in Myanmar
Aung, A. A., Ko, K., Than, K. S., Ko, A. K., & Naing, T. (2020) · Journal of the ASEAN Federation of Endocrine Societies · doi:10.15605/jafes.035.01.08
La diabetes mellitus en el contexto de la COVID-19
Campaña, C. E. M., & González, E. H. (2020) · Revista Científica Estudiantil 2 de Diciembre
The Overview of the Management of Comorbid Cardiovascular Diseases and Diabetes during COVID-19
Bakhtiarian, S., Nikandish, M., Alyari, M., & Gakharia, T. (2020) · European Scientific Journal ESJ · doi:10.19044/esj.2020.v16n36p18
Considering the Impact of Type 2 Diabetes Mellitus—Biological Mechanisms in COVID-19 Pathology
Banerjee, D., Askew, M. R., & Stephen, A. H. (2020) · touchREVIEWS in Respiratory & Pulmonary Diseases · doi:10.17925/usprd.2020.5.1.24
Diabetes mellitus and COVID-19
Faculté de médecine, U. F. A. S. 1. A., & Malek, R. (2020) · Batna Journal of Medical Sciences (BJMS) · doi:10.48087/bjmstf.2020.s715
Diabetes and COVID-19 comorbidity: Matters arising and public health implications
Reuben, R. C., Abdulkarim, H., Abdulkarim, J. H., Muhammad, F., Yakubu, A., & Adogo, L. Y. (2021) · Microbes and Infectious Diseases /Microbes and Infectious Diseases · doi:10.21608/mid.2021.62493.1121
Farmácia Azevedo, Matosinhos e Farmácia do Sameiro, Penafiel
Silva, A. R. (2021) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/y898-d695
EVENTO CORONARIANO EM DIABÉTICO PORTADOR DE INFECÇÃO POR SARS-COV-2: RELATO DE CASO
Lima, R., Carneiro, C. F., Gonzalez, J. D. C. T., Sousa, H. D. V., Filho, R. D. F. P., & Cardoso, M. D. S. D. L. (2021) · Editora Científica Digital eBooks · doi:10.37885/210102812
مراجعة/ جائحة كوفيد- 19: الآثار المترتبة على رعاية مرضى السكري والمعالجة الخاصة
الأعور, م. ص., القلعة, ط. ع., عمر, ع. ص., & العجمي, ف. ع. (2020) · مجلة العلوم الطبية و الصيدلانية · doi:10.26389/ajsrp.r160620
A Systematic Review of Relation between COVID-19 and Diabetes
Mankar, V., Dhengare, A. N., Sharma, R. P., & Chakole, S. V. (2021) · International Journal of Current Research and Review · doi:10.31782/ijcrr.2021.131014
Casas, L. Á. (2020) · Revista Colombiana de Endocrinología Diabetes & Metabolismo · doi:10.53853/encr.7.2s.582
DESVENDANDO A COVID-19 POR MEIO DA ANATOMIA PATOLÓGICA
MENDONÇA, J. C. D., Possas, E. J. P., Rodrigues, G. A., Almeida, L. D. S., Grossi, L. V. R., Souza, M. A. V. E., & Laboissière, R. S. (2021) · doi:10.22533/at.ed.5942102092
ATUALIZAÇÕES DA CORTICOTERAPIA NOS PACIENTES EM SUPORTE VENTILATÓRIO PELA COVID-19
Xavier, L. C., Assis, D. S., do Nascimento, I. C. M., Barreto, L. M. L., Borges, L. C. A., Silva, L. E. D. O., Faria, L. P., Souza, M. A. G., Brito, M. S. R., Silva, S. D. C., et al. (2021) · doi:10.22533/at.ed.59421020920
Madeira, F. O. P., Tiburcio, A. G. S., Machado, G. A., Lebourg, J. I., Santos, N. G. O. S., Campos, P. N., Silva, S. L. A. E., Vale, G. F. P., & Neto, R. M. (2021) · doi:10.22533/at.ed.59421020912
IMPACTOS CLÍNICOS E SOCIAIS CAUSADOS PELA PANDEMIA
de Almeida, B. A. D., Lorenzotti, C. D. P., Alves, G. C., Reche, G. B., Pereira, J. R., & Assis, M. R. (2021) · doi:10.22533/at.ed.5942102091
Review: COVID-19 Outbreak and Diabetic Patient’s Treatments Close Relationship
Khan, H. H., Guo, H., Achakzai, S. K., Zhao, Y., Ullah, H., Hussain, S., Ahmad, S., Nadeem, Z., Ahmad, U., Alam, K., et al. (2021) · American Journal of Nursing Science · doi:10.11648/j.ajns.20211006.11
Rola makrofagów i monocytów w infekcji SARS-CoV-2 i w ciężkim przebiegu COVID-19
Kubiak, J. Z. (2021) · Kosmos · doi:10.36921/kos.2021_2826
Mistry, S., Gouripeddi, R., & Facelli, J. C. (2021) · JAMIA Open · doi:10.1093/jamiaopen/ooab080
COVID-19 und Diabetes: Gefährliche Interaktionen
Gallwitz, B. (2020) · Deutsches Ärzteblatt · doi:10.3238/persdia.2020.10.30.01
COVID-19 and metabolic disorders: focus on the implicated molecular pathwaysPreprint
Nigro, E., Perrotta, F., Polito, R., D’Agnano, V., Scialò, F., Bianco, A., & Daniele, A. (2020) · Authorea · doi:10.22541/au.158880240.00304700
Mallick, U. (2022) · Springer eBooks · doi:10.1007/978-3-030-90065-6_16
Correlação entre ideação suicida e qualidade de vida entre diabéticos tipo 2 na pandemia
Furtado, C. C., & Alves, S. H. D. S. (2022) · Programa de Iniciação Científica - PIC/UniCEUB - Relatórios de Pesquisa · doi:10.5102/pic.n0.2020.8191
Glucose-Lowering Agents and COVID-19
Khang, A. R. (2022) · Journal of Korean Diabetes · doi:10.4093/jkd.2022.23.1.1
Unwinding Link between Coronavirus and Diabetes Patient
Bhadauria, S. S., Malviya, R., & Sharma, P. K. (2022) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530322666220329150238
Tratamento da Covid-19 em paciente pré-diabético em unidade de terapia intensiva: um relato de caso
Vieira, D. E. L. S., Souza, I. T., da Silva, R. E. R., Netto, L. S. G., de Souza, A. C. M., COUTO, J. V. T., & Cardoso, H. C. (2022) · Research Society and Development · doi:10.33448/rsd-v11i7.30146
Aleem, M., Salman, S., Iqbal, J., Khalid, M. Z., Riaz, A., & Rauf, H. A. (2022) · Pakistan Journal of Medical and Health Sciences · doi:10.53350/pjmhs2216741
Alkubaisi, S. A. S., & Alaaraji, S. F. T. (2022) · Journal of university of Anbar for pure science · doi:10.37652/juaps.2022.174833
Review on Coronavirus Disease Association with Comorbidities
Erick, Darla, & Paramita (2022) · The Review of Contemporary Scientific and Academic Studies · doi:10.55454/rcsas.2.8.2022.004
The relationship between diabetes and the severity of COVID-19Preprint
Abobaker, H. K., Abozraa, A. M. A., & Al-Bardan, H. (2022) · Research Square · doi:10.21203/rs.3.rs-2062588/v1
Professionals as Targets in the Culture Wars: A European Perspective
Morgado, P. F. (2022) · Acta Médica Portuguesa · doi:10.20344/amp.19154
Admission HbA1c value as a prognostic marker in patients admitted with COVID-19
Jain, V., & Hegde, S. S. (2022) · International Journal of Advances in Medicine · doi:10.18203/2349-3933.ijam20223020
Unveiling the prevalence and impact of diabetes on COVID-19
Banik, S. P., Bhattacharyya, M., Ghosh, R., Chatterjee, T., & Basak, P. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-85730-7.00045-x
Current management of diabetes patients with COVID-19
Misra, A. K., Rangari, G. M., Madhavrao, C., & Sharma, S. K. (2023) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2023.2187375
RetractedHypoglycemia in patients with COVID-19: risk factors and prevention of complications
Halushko, O. A., Процюк, О. В., & Pogorila, O. I. (2023) · Zaporozhye Medical Journal · doi:10.14739/2310-1210.2023.1.261797
HYPOGLYCEMIA IN PATIENTS WITH COVID-19: A COINCIDENCE OR A TREND?
Halushko, O. A., Процюк, О. В., Pogorila, O. I., & Synytsyn, M. M. (2023) · Wiadomości Lekarskie · doi:10.36740/wlek202305128
Host immune responses in COVID-19
Bandopadhyay, P., & Ganguly, D. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-18769-8.00009-x
Benacon, G. S., & Jezini, D. L. (2022) · Revista do Hospital Universitário Getúlio Vargas · doi:10.60104/revhugv10021
COVID-19 Infection and Diabetes
Gomaa, A. F., Elghmary, R. M., Sharafeddin, M., Mohamed, S. Y., & Elsayed, A. F. (2023) · Infectious Diseases in Clinical Practice · doi:10.1097/ipc.0000000000001295
COVID-19 ve Güncel Endokrinolojik Yaklaşımlar
Demirbaş, A., Aydemir, M., CANDAN, B. F., Ateş, C., Haytaoğlu, M. G., Demirtaş, L., Altuntaş, S. Ç., Genç, S., Tazegül, G., Kılıç, A. F., et al. (2022) · Akademisyen Kitabevi eBooks · doi:10.37609/akya.975
The Association between Diabetes Mellitus and Covid-19: A Systematic Review
K, S. S. K. S. S., & Cyriac, K. S. (2024) · International Journal of Pharmaceutical Research and Applications · doi:10.35629/4494-0906341352
Liu, L., He, Z., Tao, S., Hu, H., Duan, J., Ouyang, Y., Ma, L., Bao, J., Sha, T., Zhang, Y., et al. (2025) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-025-01468-z
Metadata
- Authors
- Drucker, D. J.
- Affiliations
- Mount Sinai Hospital (CA)
- Corresponding author
- Drucker, Daniel J
- ORCID
- Drucker, Daniel J
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2020-04-15
- Volume
- 41
- Issue
- 3
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- PMC
- PMC7184382
- OpenAlex
- W3015989800
- Cited by
- 399
- References
- 132
- Citations by year
- 2026: 5 · 2025: 9 · 2024: 13 · 2023: 37 · 2022: 72 · 2021: 100 · 2020: 162
- FWCI
- 14.19
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- Endocrine Reviews (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Novo Nordisk Fonden (NNF19SA0035502)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Keywords
- type 2 diabetes, COVID-19 pandemic, SARS-CoV-2, ACE2, dipeptidyl peptidase IV, DPP-4 inhibitors, glucose-lowering agents, immunomodulation, glucose homeostasis, inflammation
- MeSH terms
- Betacoronavirus, Receptors, Coronavirus, Angiotensin-Converting Enzyme 2, COVID-19, SARS-CoV-2, Animals, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Humans, Insulin, Peptidyl-Dipeptidase A, Lung, Obesity, Pneumonia, Viral, Receptors, Virus, Risk Factors, Serine Endopeptidases, Coronavirus Infections, Dipeptidyl Peptidase 4, Gastrointestinal Tract, Dipeptidyl-Peptidase IV Inhibitors, Pandemics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.